Win Some, Lose Some: Amid Otsuka-Jnana Deal, Delaware Court Favors Lupin For gJynarque

 
• By Vibha Ravi

Otsuka Pharma’s acquisition of Jnana seems like a win for its pipeline, but the Japanese major faced a setback in a Delaware District Court where the judge’s opinion put challenger Lupin closer to a generic to its Jynarque (tolvaptan)

Win some, Lose some
Otsuka Faces Loss Of Exclusivity For Jynarque In The US • Source: Shutterstock

More from Business

More from Scrip